Veristat Acquires European Medical Writing Consultancy Scinopsis
Expands Medical Writing Team, Helping Sponsors Communicate the Value of Their Data Globally
Veristat Welcomes Three New Leaders to Executive Team, Driving Global Growth and Regulatory Success in Clinical Research
Veristat Delivered a Full Range of Clinical Trial Services Culminating in Marketing Authorization of HIPRA’s SARS-CoV-2 Vaccine and...
Supporting Its Continued Commitment During Rare Disease Month to Making a Difference in the Lives of Patients Faced with Limited Treatment...
Highlights the unique advantages its DCT solutions hold for small to mid-size biotechs conducting trials for complex diseases
Advances commitment to support patient needs across diverse populations
Veristat’s Bold Thinking and World Class Clinical, Regulatory and Commercialization Capabilities Allow the Company to Successfully Tackle...
Veristat congratulates Awakn for being awarded UK State Funding to Identify Optimal Pathway to Market In UK & US For Its Lead Clinical...
Instrumental to Veristat’s growth, success, and client satisfaction over the last 15 years